je.st
news
IntegraGen Presents Results of Two Studies during 2015 ASCO Meeting...
2015-06-01 20:27:19| Logistics - Topix.net
IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in oncology and autism, today announced the presentation of two studies during the 2015 American Society of Clinical Oncology Annual Meeting focusing on the association between miR-31-3p expression and clinical outcomes in metastatic colorectal cancer patients treated with panitumumab or cetuximab. The data presented further validates previous studies which have documented that miR-31-3p expression in the primary tumor of mCRC patients is predictive of the effect of anti-EGFR therapy.
Tags: results
studies
meeting
presents
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||